Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis

Prothymosin-α (PTMA), a nuclear protein, is strikingly associated with unfavorable clinical outcomes in many cancers. However, no information about its clinical relevance in glioma was available. Therefore in the present study, we evaluated the prognostic utility of this protein in a cohort of 81 gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anurag, Kumar, Vikas, Arora, Mohit, Kumar, Manish, Ammalli, Prajwal, Thakur, Bhaskar, Prasad, Jitender, Kumari, Sarita, Sharma, Mehar Chand, Kale, Shashank Sharad, Chauhan, Shyam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069441/
https://www.ncbi.nlm.nih.gov/pubmed/35297481
http://dx.doi.org/10.1042/BSR20212685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069441/
https://www.ncbi.nlm.nih.gov/pubmed/35297481
http://dx.doi.org/10.1042/BSR20212685

Ejemplares similares